Supplemental Guarantor and Non-Guarantor Financial Information (Tables)

12 Months Ended

Dec. 31, 2012

Supplemental Guarantor and Non-Guarantor Financial Information [Abstract]

December 31, 2012

(In thousands)



	Gentiva Health Services, Inc.		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Consolidated Total
ASSETS
Current assets:
Cash and cash equivalents	$	166,140	$	—	$	40,912	$	—		$	207,052
Receivables, net	—		245,191		19,744		(13,855		)	251,080
Deferred tax assets, net	—		10,280		1,983		—			12,263
Prepaid expenses and other current assets	—		36,899		8,733		—			45,632
Total current assets	166,140		292,370		71,372		(13,855		)	516,027
Notes receivable from CareCentrix	—		28,471		—		—			28,471
Fixed assets, net	—		41,066		348		—			41,414
Intangible assets, net	—		193,513		100		—			193,613
Goodwill	—		650,300		6,064		—			656,364
Investment in subsidiaries	1,002,204		27,210		—		(1,029,414		)	—
Other assets	—		75,039		6		—			75,045
Total assets	$	1,168,344	$	1,307,969	$	77,890	$	(1,043,269	)	$	1,510,934
LIABILITIES AND EQUITY
Current liabilities:
Current portion of long-term debt	$	25,000	$	—	$	—	$	—		$	25,000
Accounts payable	—		27,300		—		(13,855		)	13,445
Other current liabilities	—		202,321		49,133		—			251,454
Total current liabilities	25,000		229,621		49,133		(13,855		)	289,899
Long-term debt	910,182		—		—		—			910,182
Deferred tax liabilities, net	—		42,165		—		—			42,165
Other liabilities	—		33,979		9		—			33,988
Total Gentiva shareholders’ equity	233,162		1,002,204		27,210		(1,029,414		)	233,162
Noncontrolling interests	—		—		1,538		—			1,538
Total equity	233,162		1,002,204		28,748		(1,029,414		)	234,700
Total liabilities and equity	$	1,168,344	$	1,307,969	$	77,890	$	(1,043,269	)	$	1,510,934

Condensed Consolidating Balance Sheet

December 31, 2011

(In thousands)



	Gentiva Health Services, Inc.		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Consolidated Total
ASSETS
Current assets:
Cash and cash equivalents	$	124,101	$	—	$	40,811	$	—		$	164,912
Receivables, net	—		283,552		18,168		(11,131		)	290,589
Deferred tax assets, net	—		24,560		1,891		—			26,451
Prepaid expenses and other current assets	—		32,619		6,904		(1,144		)	38,379
Total current assets	124,101		340,731		67,774		(12,275		)	520,331
Note receivable from CareCentrix	—		25,000		—		—			25,000
Fixed assets, net	—		45,917		329		—			46,246
Intangible assets, net	—		214,774		100		—			214,874
Goodwill	—		635,605		6,064		—			641,669
Investment in subsidiaries	1,063,962		25,173		—		(1,089,135		)	—
Other assets	—		82,200		8		—			82,208
Total assets	$	1,188,063	$	1,369,400	$	74,275	$	(1,101,410	)	$	1,530,328
LIABILITIES AND EQUITY
Current liabilities:
Current portion of long-term debt	$	14,903	$	—	$	—	$	—		$	14,903
Accounts payable	—		22,913		831		(11,131		)	12,613
Other current liabilities	—		223,165		45,655		(1,144		)	267,676
Total current liabilities	14,903		246,078		46,486		(12,275		)	295,192
Long-term debt	973,222		—		—		—			973,222
Deferred tax liabilities, net	—		32,498		—		—			32,498
Other liabilities	—		26,862		23		—			26,885
Total Gentiva shareholders’ equity	199,938		1,063,962		25,173		(1,089,135		)	199,938
Noncontrolling interests	—		—		2,593		—			2,593
Total equity	199,938		1,063,962		27,766		(1,089,135		)	202,531
Total liabilities and equity	$	1,188,063	$	1,369,400	$	74,275	$	(1,101,410	)	$	1,530,328

Condensed Consolidating Statement of Comprehensive Income

For the Year Ended December 31, 2012

(In thousands)



	Gentiva Health Services, Inc.			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated Total
Net revenues	$	—		$	1,666,368		$	61,656		$	(15,220	)	$	1,712,804
Cost of services sold	—			884,903			39,058			(15,220		)	908,741
Gross profit	—			781,465			22,598			—			804,063
Selling, general and administrative expenses	—			(638,975		)	(16,791		)	—			(655,766		)
Goodwill, intangibles and other long-lived asset impairment	—			(19,132		)	—			—			(19,132		)
Gain on sale of assets and businesses, net	—			8,014			—			—			8,014
Interest (expense) and other, net	(90,054		)	—			107			—			(89,947		)
Equity in earnings of subsidiaries	79,622			3,038			—			(82,660		)	—
(Loss) income from continuing operations before income taxes and equity in net earnings of CareCentrix	(10,432		)	134,410			5,914			(82,660		)	47,232
Income tax benefit (expense)	37,228			(52,487		)	(1,992		)	—			(17,251		)
Equity in net (loss) earnings of CareCentrix	—			(2,301		)	—			—			(2,301		)
Income from continuing operations	26,796			79,622			3,922			(82,660		)	27,680
Discontinued operations, net of tax	—			—			—			—			—
Net income	26,796			79,622			3,922			(82,660		)	27,680
Noncontrolling interests	—			—			(884		)	—			(884		)
Net income attributable to Gentiva shareholders	$	26,796		$	79,622		$	3,038		$	(82,660	)	$	26,796
Comprehensive income	$	26,796		$	79,622		$	3,922		$	(82,660	)	$	27,680

Condensed Consolidating Statement of Comprehensive Income

For the Year Ended December 31, 2011

(In thousands)



	Gentiva Health Services, Inc.			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated Total
Net revenues	$	—		$	1,757,459		$	52,404		$	(11,085	)	$	1,798,778
Cost of services sold	—			921,826			37,714			(11,085		)	948,455
Gross profit	—			835,633			14,690			—			850,323
Selling, general and administrative expenses	—			(715,343		)	(15,064		)	—			(730,407		)
Goodwill, intangibles and other long-lived asset impairment	—			(643,305		)	—			—			(643,305		)
Gain on sale of assets and businesses, net	—			1,061			—			—			1,061
Dividend income	—			8,590			—			—			8,590
Interest (expense) and other, net	(88,665		)	—			55			—			(88,610		)
Equity in earnings of subsidiaries	(380,176		)	221			—			379,955			—
Loss from continuing operations before income taxes and equity in net earnings of CareCentrix	(468,841		)	(513,143		)	(319		)	379,955			(602,348		)
Income tax benefit (expense)	18,316			56,637			815			—			75,768
Equity in net earnings of CareCentrix	—			68,381			—			—			68,381
(Loss) income from continuing operations	(450,525		)	(388,125		)	496			379,955			(458,199		)
Discontinued operations, net of tax	—			7,949			366			—			8,315
Net (loss) income	(450,525		)	(380,176		)	862			379,955			(449,884		)
Noncontrolling interests	—			—			(641		)	—			(641		)
Net (loss) income attributable to Gentiva shareholders	$	(450,525	)	$	(380,176	)	$	221		$	379,955		$	(450,525	)
Comprehensive (loss) income	$	(451,003	)	$	(380,176	)	$	862		$	379,955		$	(450,362	)

Condensed Consolidating Statement of Comprehensive Income

For the Year Ended December 31, 2010

(In thousands)



	Gentiva Health Services, Inc.			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated Total
Net revenues	$	—		$	1,388,234		$	38,463		$	(12,238	)	$	1,414,459
Cost of services sold	—			667,389			24,923			(12,238		)	680,074
Gross profit	—			720,845			13,540			—			734,385
Selling, general and administrative expenses	—			(596,874		)	(9,990		)	—			(606,864		)
Gain on sale of businesses	—			103			—			—			103
Interest (expense) and other, net	(39,097		)	—			67			—			(39,030		)
Equity in earnings of subsidiaries	75,652			2,033			—			(77,685		)	—
Income from continuing operations before income taxes and equity in net earnings of CareCentrix	36,555			126,107			3,617			(77,685		)	88,594
Income tax benefit (expense)	15,600			(48,336		)	(1,340		)	—			(34,076		)
Equity in net earnings of CareCentrix	—			1,298			—			—			1,298
Income from continuing operations	52,155			79,069			2,277			(77,685		)	55,816
Discontinued operations, net of tax	—			(3,417		)	282			—			(3,135		)
Net income	52,155			75,652			2,559			(77,685		)	52,681
Noncontrolling interests	—			—			(526		)	—			(526		)
Net income attributable to Gentiva shareholders	$	52,155		$	75,652		$	2,033		$	(77,685	)	$	52,155
Comprehensive income	$	52,633		$	75,652		$	2,559		$	(77,685	)	$	53,159

Condensed Consolidating Statement of Cash Flows

For the Year Ended December 31, 2012

(In thousands)



	Gentiva Health Services, Inc.			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations		Consolidated Total
OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	$	(18,089	)	$	138,316		$	5,741		$	—	$	125,968
INVESTING ACTIVITIES:
Purchase of fixed assets	—			(11,609		)	(170		)	—		(11,779		)
Proceeds from sale of businesses	—			9,220			—			—		9,220
Acquisition of businesses	—			(22,335		)	—			—		(22,335		)
Net cash used in investing activities	—			(24,724		)	(170		)	—		(24,894		)
FINANCING ACTIVITIES:
Proceeds from issuance of common stock	3,980			—			—			—		3,980
Windfall tax benefits associated with equity-based compensation	88			—			—			—		88
Repayment of long-term debt	(52,943		)	—			—			—		(52,943		)
Debt issuance costs	(4,125		)	—			—			—		(4,125		)
Repurchase of common stock	(4,974		)	—			—			—		(4,974		)
Repayment of capital lease obligations	(135		)	—			—			—		(135		)
Other	4,673			(28		)	(5,470		)	—		(825		)
Net payments related to intercompany financing	113,564			(113,564		)	—			—		—
Net cash provided by (used in) financing activities	60,128			(113,592		)	(5,470		)	—		(58,934		)
Net change in cash and cash equivalents	42,039			—			101			—		42,140
Cash and cash equivalents at beginning of period	124,101			—			40,811			—		164,912
Cash and cash equivalents at end of period	$	166,140		$	—		$	40,912		$	—	$	207,052

Condensed Consolidating Statement of Cash Flows

For the Year Ended December 31, 2011

(In thousands)



	Gentiva Health Services, Inc.			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations		Consolidated Total
OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	$	(46,730	)	$	51,221		$	650		$	—	$	5,141
INVESTING ACTIVITIES:
Purchase of fixed assets	—			(19,053		)	(178		)	—		(19,231		)
Proceeds from sale of businesses	—			146,261			54			—		146,315
Acquisition of businesses	—			(320		)	—			—		(320		)
Net cash provided by (used in) investing activities	—			126,888			(124		)	—		126,764
FINANCING ACTIVITIES:
Proceeds from issuance of common stock	7,901			—			—			—		7,901
Windfall tax benefits associated with equity-based compensation	192			—			—			—		192
Repayment of long-term debt	(63,438		)	—			—			—		(63,438		)
Debt issuance costs	(15,460		)	—			—			—		(15,460		)
Repayment of capital lease obligations	(267		)	—			—			—		(267		)
Other	—			(22		)	(651		)	—		(673		)
Net payments related to intercompany financing	178,087			(178,087		)	—			—		—
Net cash provided by (used in) financing activities	107,015			(178,109		)	(651		)	—		(71,745		)
Net change in cash and cash equivalents	60,285			—			(125		)	—		60,160
Cash and cash equivalents at beginning of period	63,816			—			40,936			—		104,752
Cash and cash equivalents at end of period	$	124,101		$	—		$	40,811		$	—	$	164,912

Condensed Consolidating Statement of Cash Flows

For the Year Ended December 31, 2010

(In thousands)



	Gentiva Health Services, Inc.			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations		Consolidated Total
OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	$	(13,150	)	$	156,227		$	(456	)	$	—	$	142,621
INVESTING ACTIVITIES:
Purchase of fixed assets	—			(15,947		)	(237		)	—		(16,184		)
Proceeds from sale of businesses	—			9,796			—			—		9,796
Acquisition of businesses	—			(834,919		)	—			—		(834,919		)
Net cash used in investing activities	—			(841,070		)	(237		)	—		(841,307		)
FINANCING ACTIVITIES:
Proceeds from issuance of common stock	8,618			—			—			—		8,618
Windfall tax benefits associated with equity-based compensation	948			—			—			—		948
Proceeds from issuance of debt	1,075,000			—			—			—		1,075,000
Borrowings under revolving credit facility	30,000			—			—			—		30,000
Repayment under revolving credit facility	(30,000		)	—			—			—		(30,000		)
Repayment of long-term debt	(260,437		)	—			—			—		(260,437		)
Repayment of Odyssey long-term debt	—			(108,822		)	—			—		(108,822		)
Debt issuance costs	(58,577		)	—			—			—		(58,577		)
Repurchase of common stock	(4,985		)	—			—			—		(4,985		)
Repayment of capital lease obligations	(645		)	—			—			—		(645		)
Other	(72		)	—			—			—		(72		)
Net payments related to intercompany financing	(796,095		)	793,665			2,430			—		—
Net cash (used in) provided by financing activities	(36,245		)	684,843			2,430			—		651,028
Net change in cash and cash equivalents	(49,395		)	—			1,737			—		(47,658		)
Cash and cash equivalents at beginning of period	113,211			—			39,199			—		152,410
Cash and cash equivalents at end of period	$	63,816		$	—		$	40,936		$	—	$	104,752